Sign in

CIK 0002012593 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Rapport Therapeutics, Inc.

Sign in to watch
Ticker
RAPP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
880724208
Phone
857-321-8020
Business address
99 HIGH STREET, SUITE 2100, BOSTON, MA, 02110
Former names
Rapport Therapeutics, Inc.
Open-market buys, last 90 days
$22,023,904
in 7 filings
Open-market sales, last 90 days
$4,490,340
in 8 filings, $4.5M under 10b5-1 plans

Net +$17,533,565. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. HEALY JAMES +$20.4M Director 1 filing
  2. Yeleswaram Krishnaswamy −$2.6M Chief Development Officer sold 21% of stake
  3. Ceesay Abraham −$1.6M Chief Executive Officer sold 7% of stake
  4. PAUL STEVEN M +$974K Director 1 filing
  5. Gault Cheryl −$332K Chief Operating Officer sold 7% of stake
Date Insider Transaction Shares Price Value Owned after
2026-06-30 Gault Cheryl Chief Operating Officer Sale 10b5-1 −1,000 $43.15 $43K 149,914
2026-06-29 Ceesay Abraham Chief Executive Officer Sale 10b5-1 −7,344 $39.77 $292K 548,903
2026-06-29 Ceesay Abraham Chief Executive Officer Sale 10b5-1 −876 $40.34 $35K 548,027
2026-06-10 MARAGANORE JOHN Director Grant or award · Stock Option (Right to Buy) +15,200 15,200
2026-06-10 PEREZ ROBERT J Director Grant or award · Stock Option (Right to Buy) +15,200 15,200
2026-06-10 PAUL STEVEN M Director Grant or award · Stock Option (Right to Buy) +15,200 15,200
2026-06-10 Silva Paul M Director Grant or award · Stock Option (Right to Buy) +15,200 15,200
2026-06-10 HEALY JAMES Director Grant or award · Stock Option (Right to Buy) +15,200 15,200
2026-06-10 Huber Reid M Director Grant or award · Stock Option (Right to Buy) +15,200 15,200
2026-06-10 Young Wendy B. Director Grant or award · Stock Option (Right to Buy) +15,200 15,200
2026-06-10 Sanchez Ramiro Director Grant or award · Stock Option (Right to Buy) +15,200 15,200
2026-05-26 Third Rock Ventures V, L.P. 10% owner Sale 10b5-1 −18,572 $40.05 $744K 6,280,525
2026-05-11 Third Rock Ventures V, L.P. 10% owner Sale 10b5-1 −133,618 $40.24 $5.4M 6,299,097
2026-05-08 Third Rock Ventures V, L.P. 10% owner Sale 10b5-1 −5,018 $40.31 $202K 6,432,715
2026-05-07 Third Rock Ventures V, L.P. 10% owner Sale 10b5-1 −271,495 $40.12 $10.9M 6,437,733
2026-04-17 Third Rock Ventures V, L.P. 10% owner Sale 10b5-1 −426,005 $40.32 $17.2M 6,709,228
2026-04-17 Yeleswaram Krishnaswamy Chief Development Officer Sale 10b5-1 −20,225 $39.99 $809K 246,426
2026-04-14 Yeleswaram Krishnaswamy Chief Development Officer Sale 10b5-1 −10,200 $35.08 $358K 266,651
2026-04-13 Yeleswaram Krishnaswamy Chief Development Officer Sale 10b5-1 −9,165 $34.97 $321K 276,851
2026-04-10 Yeleswaram Krishnaswamy Chief Development Officer Sale 10b5-1 −500 $34.98 $17K 286,016

Page 3 of 10 · 186 trades